MANAR EISSA

Mrs. MANAR EISSA


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2020 in Processes
Verified
Journal Article
Open access
PDF file
MEMANAR EISSA
MANAR EISSA
YHYUMI ZUHANIS HAS-YUN Hashim
YUMI ZUHANIS HAS-YUN Hashim
DEDina El-Kersh
Dina El-Kersh
SASaripah S. S. Abd-Azziz
Saripah S. S. Abd-Azziz
HSHamzah Mohd. Salleh
Hamzah Mohd. Salleh
NWNor Malia Abd Warif
Nor Malia Abd Warif
The Aquilaria malaccensis species of the genus Aquilaria is an abundant source of agarwood resin and many bioactive phytochemicals. Recent data regarding the chemical constituents and biological activities of Aquilaria leaves led us to attempt to qualitatively profile the metabolites of Aquilaria malaccensis leaves from a healthy, noninoculated tree through phytochemical screening, GC-MS, and LC/Q-TOF-MS. The present work is also the first to report the antilipoxygenase activity of A. malaccensis leaves from healthy noninoculated tree and investigate its toxicity on oral mucosal cells. A total of 53 compounds were tentatively identified in the extract, some of which have been described in literature as exhibiting anti-inflammatory activity. A number of compounds were identified for the first time in the extract of A. malaccensis leaf, including quercetin, quercetin-O-hexoside, kaempferol-O-dirhamnoside, isorhamnetin-O-hexoside, syringetin-O-hexoside, myricetin, tetrahydroxyflavanone, hesperetin, sissotrin, and lupeol. The antilipoxygenase assay was used to determine the lipoxygenase (LOX) inhibitory potential of the extract, while a WST-1 assay was conducted to investigate the effect of the extract on oral epithelial cells (OEC). The extract implied moderate anti-LOX activity with IC50 value of 71.6 µg/mL. Meanwhile, the cell viability of OEC ranged between 92.55% (10 µg/mL)–76.06% ± (100 µg/mL) upon treatment, indicating some potential toxicity risks. The results attained encourage future studies of the isolation of bioactive compounds from Aquilaria malaccensis leaves, as well as further investigation on the anti-inflammatory mechanisms and toxicity associated with their use.

26 April 2022 in ACS Omega
Verified
Journal Article
Open access
MEMANAR EISSA
MANAR EISSA
YHYumi Z. H-Y. Hashim
Yumi Z. H-Y. Hashim
SASaripah S. S. Abdul Azziz
Saripah S. S. Abdul Azziz
HSHamzah Mohd. Salleh
Hamzah Mohd. Salleh
MIMuhammad Lokman Md. Isa
Muhammad Lokman Md. Isa
DEDina El-Kersh
Dina El-Kersh
This study aims to identify the major phytochemical constituents in Aquilaria malaccensis (Thymelaeaceae) ethanolic leaf extract (ALEX-M) and elucidate their ability to suppress nitric oxide (NO) production from a murine macrophage-like cell line (RAW 264.7) stimulated by lipopolysaccharide (LPS) and interferon-γ (IFN-γ). Dichloromethane (DCM) and ethyl acetate (EtOAc) fractions of ALEX-M were subjected to column chromatography. Eight known compounds were isolated for the first time from this species. Compounds were identified using spectroscopic techniques (IR, UV, HRESIMS, and 1D and 2D NMR). Anti-inflammatory activity of both extract and isolated compounds were investigated in vitro. The fractions offered the isolation of epifriedelanol (1), 5-hydroxy-7,4'-dimethoxyflavone (2), luteolin-7,3',4'-trimethyl ether (3), luteolin-7,4'-dimethyl ether (4), acacetin (5), aquilarinenside E (6), iriflophenone-2-O-α-l-rhamnopyranoside (7), and iriflophenone-3-C-β-glucoside (8). The findings suggest the pharmacological potential of the crude extract (ALEX-M) and its isolates as natural anti-inflammatory agents, capable of suppressing NO production in RAW 264.7 cells stimulated by LPS/IFN-γ.

1 January 2021 in Drug Delivery
Verified
Journal Article
Open access
MEMANAR EISSA
MANAR EISSA
YHYumi Z. H.-Y. Hashim
Yumi Z. H.-Y. Hashim
MNMohd Hamzah Mohd Nasir
Mohd Hamzah Mohd Nasir
YNYusilawati Ahmad Nor
Yusilawati Ahmad Nor
HSHamzah Mohd. Salleh
Hamzah Mohd. Salleh
NBNoha M. Badawi
Noha M. Badawi
Aquilaria malaccensis has been traditionally used to treat several medical disorders including inflammation. However, the traditional claims of this plant as an anti-inflammatory agent has not been substantially evaluated using modern scientific techniques. The main objective of this study was to evaluate the anti-inflammatory effect of Aquilaria malacensis leaf extract (ALEX-M) and potentiate its activity through nano-encapsulation. The extract-loaded nanocapsules were fabricated using water-in-oil-in-water (w/o/w) emulsion method and characterized via multiple techniques including DLS, TEM, FTIR, and TGA. The toxicity and the anti-inflammatory activity of ALEX-M and the extract-loaded nanocapsules (ALEX-M-PNCs) were evaluated in-vitro on RAW 264.7 macrophages and in-vivo on zebrafish embryos. The nanocapsules demonstrated spherical shape with mean particle diameter of 167.13 ± 1.24 nm, narrow size distribution (PDI = 0.29 ± 0.01), and high encapsulation efficiency (87.36 ± 1.81%). ALEX-M demonstrated high viability at high concentrations in RAW 264.7 cells and zebrafish embryos, however, ALEX-M-PNCs showed relatively higher cytotoxicity. Both free and nanoencapsulated extract expressed anti-inflammatory effects through significant reduction of the pro-inflammatory mediator nitric oxide (NO) production in LPS/IFNγ-stimulated RAW 264.7 macrophages and zebrafish embryos in a concentration-dependent manner. The findings highlight that ALEX-M can be recognized as a potential anti-inflammatory agent, and its anti-inflammatory activity can be potentiated by nano-encapsulation. Further studies are warranted toward investigation of the mechanistic and immunomodulatory roles of ALEX-M.

26 November 2025 in Endocrinology
Verified
Journal Article
Open access
AAAhmed M Abdelhameed
Ahmed M Abdelhameed
MEMANAR EISSA
MANAR EISSA
KTKatie Thompson
Katie Thompson
KEKristin of Mississippi Medical Edwards
Kristin of Mississippi Medical Edwards
NHNgoc H Hoang
Ngoc H Hoang
LCLicy L. Yanes Cardozo
Licy L. Yanes Cardozo
Polycystic ovary syndrome (PCOS) is associated with a high prevalence of insulin resistance (IR) and obesity. Adiponectin, an insulin-sensitizing hormone, is reduced in PCOS and inversely correlated with IR and obesity. This study tested whether androgens reduce adiponectin, and if the adiponectin receptor agonist AdipoRon improves IR and obesity in a PCOS model. Four-week-old female Sprague Dawley rats were implanted with dihydrotestosterone (DHT) or control Silastic tubes for 12 weeks. After 6 weeks of DHT treatment, rats received AdipoRon or vehicle in their food for 6 weeks. DHT increased body weight, fat and lean mass, food intake, serum leptin, adipose mitochondrial oxidative stress, inflammatory markers, HOMA-IR, adipocyte size, and decreased serum adiponectin levels. DHT upregulated GLUT4, PPARγ, and adiponectin mRNA expression in subcutaneous adipose tissue (SAT), while PPARγ was downregulated in visceral adipose tissue (VAT). DHT also reduced Akt protein expression in SAT and p(S473)-Akt phosphorylation in VAT and caused a depot-specific effect on androgen receptor expression. AdipoRon reduced body weight, fat, and lean mass, food intake, serum leptin, adipocyte size, and IR markers in DHT-treated rats. AdipoRon upregulated Akt, AMPK, and AdipoR1 mRNA expression in SAT and increased p(S473)-Akt phosphorylation in both white adipose tissue (WAT) depots. AdipoRon also reduced mitochondrial oxidative stress in both WAT depots and decreased androgen receptor expression in VAT. AdipoRon attenuates hyperandrogenemia-induced adiposity and IR in a PCOS model by improving adipose insulin and adiponectin signaling, reducing mitochondrial oxidative stress and food intake, supporting its therapeutic potential in managing IR and obesity in PCOS women.

4 October 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MEMANAR EISSA
MANAR EISSA
Mohamed FaragMohamed Farag
Mohamed Farag
DSDalia O. Saleh
Dalia O. Saleh
MSMarwa E. Shabana
Marwa E. Shabana
RERania F. Abou El-Ezz
Rania F. Abou El-Ezz
DEDina M. El-Kersh
Dina M. El-Kersh

5 September 2018
Verified
Book Chapter
Open access
PDF file
YHYUMI ZUHANIS HAS-YUN Hashim
YUMI ZUHANIS HAS-YUN Hashim
HSHamzah Mohd. Salleh
Hamzah Mohd. Salleh
NPNoor Illi Mohamad Puad
Noor Illi Mohamad Puad
FFFazia Adyani Ahmad Fuad
Fazia Adyani Ahmad Fuad
MEMANAR EISSA
MANAR EISSA
NZNur Aimi Aliah Zainurin
Nur Aimi Aliah Zainurin
Herbal medicine is gaining acceptance worldwide for their effective pharmacological effects and relative safety. Plants have metabolic pathways that lead to the production and accumulation of secondary metabolites such as alkaloids, glycosides, and terpenoids that exhibit various biological activities. Plant secondary metabolites have been the major foci of investigation for several years and have been successfully used against a number of communicable and noncommunicable diseases such as diabetes, cancer, and viral infections. This chapter will explore Malaysian plants, their secondary metabolites, and their biological/medicinal properties with a particular focus on some selected species under a national project. Other aspects such as plant tissue culture to produce secondary metabolites and a case study on the use of secondary metabolites in the prevention and treatment of dengue fever are also described. While a lot of effort has been put in, further research and development into plant secondary metabolites are needed including using the plant tissue culture approach toward reaching high-value herbal industry.